You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PALB2 Mutation

Showing 26 - 50 of 6,468
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

Not yet recruiting
  • GATA2 Gene Mutation
  • Biological samples (blood and bone marrow samples).
  • Angers, France
  • +16 more
Jul 31, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Biospecimen Collection
  • +4 more
  • Anchorage, Alaska
  • +357 more
Jan 28, 2023

Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

Recruiting
  • Metastatic Solid Tumor
  • +4 more
  • Recommendation for treatment with immunotherapy
  • Baltimore, Maryland
    Johns Hopkins University
Sep 8, 2022

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

Not yet recruiting
  • Cholangiocarcinoma Non-resectable
  • Cholangiocarcinoma Metastatic
  • (no location specified)
Oct 10, 2023

NSCLC Trial in Guangzhou (PLB1001)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 15, 2023

Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))

Not yet recruiting
  • Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Tazverik (Tazemetostat)
  • (no location specified)
Oct 6, 2023

Registry of Subjects at Risk of Pancreatic Cancer

Recruiting
  • Familial Pancreatic Cancer
  • +6 more
  • MRCP
  • Endoultrasonography
  • Rozzano, Milan, Italy
  • +3 more
Jan 12, 2023

NSCLC Trial in Shanghai (RC48-ADC, Pyrotinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Feb 16, 2023

Lazertinib as the 2nd-Line Treatment in EGFR Mutation+ NSCLC

Completed
  • Non-small Cell Lung Cancer
  • (no location specified)
May 8, 2023

Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

Recruiting
  • Breast Cancer
  • Genetic Predisposition
  • Genetic predisposition to breast cancer
  • Rome, Italy
  • +1 more
May 4, 2023

BRCA1/2 Flu Vaccine

Active, not recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Seasonal influenza vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 16, 2022

Carotid Plaque Burden in Philadelphia Negative

Recruiting
  • Myeloproliferative Neoplasm
    • Sohag, Egypt
      Faculty of Medicine
    Aug 14, 2023

    Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

    Not yet recruiting
    • Solid Tumor
    • +4 more
    • (no location specified)
    Feb 21, 2023

    Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

    Recruiting
    • Recurrent IDH1/2 Mutated Glioma
    • Paris, France
      Pitie Salpetriere Hospital
    Aug 29, 2022

    Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

    Not yet recruiting
    • Solid Tumor, Adult
    • +4 more
    • (no location specified)
    Apr 24, 2023

    Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

    Active, not recruiting
    • Efficacy
    • Oral sotorasib + IV Panitumumab
    • Seoul, Korea, Republic of
      Korea University Anam Hospital
    Aug 14, 2023

    Nonsene Mutation Duchenne Muscular Dystrophy Trial in Atlanta (Ataluren)

    Recruiting
    • Nonsene Mutation Duchenne Muscular Dystrophy
    • Atlanta, Georgia
      Rare Disease Research, LLC
    Jan 27, 2023

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

    Active, not recruiting
    Has Results
    • BRCA1 Gene Mutation
    • +5 more
    • Durvalumab
    • +3 more
    • Buffalo, New York
    • +1 more
    Jan 20, 2023

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

    Recruiting
    • ATM Gene Mutation
    • +16 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

    Recruiting
    • EGFR Exon 20 Mutation
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • +2 more
    • (no location specified)
    Oct 24, 2023

    HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)

    Not yet recruiting
    • HER2
    • Colorectal Cancer
    • Disitamab Vedotin Combined With Fruquintinib
    • (no location specified)
    Dec 21, 2022

    Pilot Study of Pancreatic Cancer Screening

    Recruiting
    • Pancreatic Carcinoma
    • Biospecimen Collection
    • +4 more
    • San Francisco, California
      University of California San Francisco
    Apr 13, 2022